Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study on the Safety and Preliminary Efficacy of UCLH80-1 Cells in Patients With CDH17-Positive Advanced Malignant Solid Tumors

NCT06937567 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06937567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06937567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study on the Safety and Preliminary Efficacy of UCLH80-1 Cells in Patients With CDH17-Positive Advanced Malignant Solid Tumors
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Recruiting
Start date
December 26, 2024
Completion date
May 30, 2028
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer, colorectal carcinoma, gastric cancer, metastatic, multiple cancer, pancreatic adenocarcinoma (ductal adenocarcinoma)